Milestone Scientific Welcomes Eric C. Hines as New CEO
Milestone Scientific Inc. (NYSE: MLSS), renowned for its groundbreaking advancements in computer-controlled drug delivery systems, has announced a significant change in its leadership. Effective immediately, Eric C. Hines has been appointed as the Chief Executive Officer of the company. This transition marks a pivotal moment for Milestone Scientific as it aims to innovate and expand its offerings in the healthcare sector.
Eric Hines: A Leader with Vision
With over 25 years of extensive experience in leading sales-focused technology enterprises, Hines holds a wealth of knowledge across various industries, especially healthcare. Prior to joining Milestone Scientific, he was the President of North America at Ex Libris, a sub-division of Clarivate. His leadership prowess was instrumental in accelerating revenue growth, more than doubling the annual income from around $50 million to beyond $100 million. During his tenure, he successfully launched several new product lines, expanded customer bases, and significantly improved service delivery.
Building on a Strong Foundation
Milestone Scientific is excited to leverage Hines’ expertise as they continue to build on their successes, particularly with their flagship CompuFlo® technology. The company has made noteworthy strides in reimbursement initiatives, including the assignment of Medicare Part B payment rates under the CPT® code 0777T. Such achievements position Milestone to strengthen their presence within both medical and dental markets, paving the way for further commercial opportunities domestically and internationally.
Strategic Focus on Innovation and Growth
In his first remarks as CEO, Eric C. Hines expressed his enthusiasm for leading Milestone Scientific at this critical juncture. He emphasized the company's strong foundation, particularly the clinically validated CompuFlo® platform. Hines revealed plans to explore new market segments, especially within dentistry, where the STA® system is already seen as a leading solution. His commitment to advancing the technology into newer clinical indications showcases his strategic vision for the company's future.
Commitment to Patient Care
Eric believes that the importance of delivering both clinical and economic value cannot be overstated. His approach aligns with Milestone’s mission to enhance patient comfort and safety through cutting-edge technology. He is keen on collaborating with the team to ensure that these innovative solutions are not only adopted but integrated into practical use for healthcare providers.
About Milestone Scientific Inc.
As a technology-centered medical research and development firm, Milestone Scientific Inc. (MLSS) focuses on innovating injection technologies and devices for medical and dental practices. Their advanced computer-controlled systems aim to streamline the injection process, ensuring precision while enhancing patient comfort. Leveraging its proprietary DPS Dynamic Pressure Sensing Technology®, the company is dedicated to advancing the next generation of medical devices designed to improve patient outcomes significantly.
Frequently Asked Questions
What is the role of the new CEO at Milestone Scientific?
Eric C. Hines will lead the company in expanding its market presence and enhancing its product offerings, especially in the medical and dental sectors.
What experience does Eric C. Hines bring to Milestone Scientific?
Hines has over 25 years of leadership experience with a strong background in scaling sales-driven technology companies across diverse sectors, including healthcare.
What technologies does Milestone Scientific focus on?
The company specializes in computerized drug delivery instruments that make injections precise and efficient, improving patient comfort significantly.
How has Milestone Scientific performed in terms of reimbursement?
Milestone Scientific has made substantial progress in securing reimbursement rates, including Medicare Part B payment assignments, enabling broader adoption of their technologies.
What are the future plans for Milestone Scientific?
The company aims to explore new clinical indications and expand its reach into international markets while reinforcing its foothold in dental and medical applications.
